Moderna Inc said on Friday it was on track to produce 20 million doses of its experimental coronavirus vaccine by the end of the year, while maintaining its goal of readying 500 million to 1 billion doses in 2021.
Russia said Saturday that it has produced the first batch of its coronavirus vaccine, after President Vladimir Putin announced it had been first in the world to approve a vaccine.
Britain will buy potential Covid-19 vaccines from US drugmakers Johnson & Johnson and Novavax Inc, the companies said on Friday, boosting the number of deals it has with drugmakers as the global vaccine race rages on.
Russia said on Wednesday the first batch of the world's first Covid-19 vaccine would be rolled out within two weeks and rejected as "groundless" safety concerns aired by some experts over Moscow's rapid approval
Germany's leading infectious disease institute said on Wednesday a first vaccine against the coronavirus could be available as early as autumn but warned that it may take longer to control the pandemic.
An announcement by Russia on Tuesday that it will approve a Covid-19 vaccine after less than two months of human testing prompted alarm among global health experts, who said that with no full trial data, the vaccine is hard to trust.
European Union Health Commissioner Stella Kyriakides said a vaccine for Covid-19 could become available by the end of 2020.
Indian drugmaker Wockhardt Ltd will supply millions of doses of multiple Covid-19 vaccines to the United Kingdom, it said on Monday.
Russia is preparing to start a mass vaccination campaign against the novel coronavirus in October, Health Minister Mikhail Murashko said on Saturday, RIA news agency reported.
Russia's first potential Covid-19 vaccine will win local regulatory approval in the first half of August and be administered to frontline health workers soon afterwards, a development source close to the matter told Reuters.
Moderna Inc plans to price its experimental coronavirus vaccine in a way that ensures broad access, it said on Wednesday, adding that it did not intend to conduct late-stage trials of the vaccine outside the United States.